BCRX
BioCryst Pharmaceuticals Inc
Price:  
5.82 
USD
Volume:  
1,867,054.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BCRX WACC - Weighted Average Cost of Capital

The WACC of BioCryst Pharmaceuticals Inc (BCRX) is 7.8%.

The Cost of Equity of BioCryst Pharmaceuticals Inc (BCRX) is 10.55%.
The Cost of Debt of BioCryst Pharmaceuticals Inc (BCRX) is 5.00%.

Range Selected
Cost of equity 8.50% - 12.60% 10.55%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.6% - 9.0% 7.8%
WACC

BCRX WACC calculation

Category Low High
Long-term bond rate 4.2% 4.7%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.94 1.33
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.50% 12.60%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.66 0.66
Cost of debt 5.00% 5.00%
After-tax WACC 6.6% 9.0%
Selected WACC 7.8%